My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
WA State Allocation Agreement of funds paid from Opioid Settlements
>
Meetings
>
2025
>
09. September
>
2025-09-16 10:00 AM - Commissioners' Agenda
>
WA State Allocation Agreement of funds paid from Opioid Settlements
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
9/11/2025 12:15:37 PM
Creation date
9/11/2025 12:14:08 PM
Metadata
Fields
Template:
Meeting
Date
9/16/2025
Meeting title
Commissioners' Agenda
Location
Commissioners' Auditorium
Address
205 West 5th Room 109 - Ellensburg
Meeting type
Regular
Meeting document type
Supporting documentation
Supplemental fields
Item
Request to Approve a Resolution Authorizing Acceptance and County Participation in the Washington State Allocation Agreement of Funds Paid by the Purdue Bankruptcy and Certain Opioid Manufactures and Authorizing Commissioner Signature on All Required Participation Forms
Order
2
Placement
Consent Agenda
Row ID
135628
Type
Resolution
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
50
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
6. Nothing in this MOU should alter or change any Participating <br />Local Government's rights to pursue its own claim. Rather, the intent of <br />this MOU is to join all parties who wish to be Participating Local <br />Governments to agree upon an allocation formula for any Opioid Funds <br />from any future binding Settlement with one or more Pharmaceutical <br />Supply Chain Participants for all Local Governments in the State of <br />Washington. <br />7. If any Participating Local Government disputes the amount it <br />receives from its allocation of Opioid Funds, the Participating Local <br />Government shall alert its respective OAC within sixty (60) days of <br />discovering the information underlying the dispute. Failure to alert its <br />OAC within this time frame shall not constitute a waiver of the <br />Participating Local Government's right to seek recoupment of any <br />deficiency in its allocation of Opioid Funds. <br />8. If any OAC concludes that a Participating Local Government's <br />expenditure of its allocation of Opioid Funds did not comply with the <br />Approved Purposes listed in Exhibit A, or the terms of this MOU, or that <br />the Participating Local Government otherwise misused its allocation of <br />Opioid Funds, the OAC may take remedial action against the alleged <br />offending Participating Local Government. Such remedial action is left to <br />the discretion of the OAC and may include withholding future Opioid <br />Funds owed to the offending Participating Local Government or requiring <br />the offending Participating Local Government to reimburse improperly <br />expended Opioid Funds back to the OAC to be re-allocated to the <br />remaining Participating Local Governments within that Region. <br />9. All Participating Local Governments and OAC shall maintain all <br />records related to the receipt and expenditure of Opioid Funds for no less <br />than five (5) years and shall make such records available for review by <br />any other Participating Local Government or OAC, or the public. Records <br />requested by the public shall be produced in accordance with <br />Washington's Public Records Act RCW 42.56.001 et seq. Records <br />requested by another Participating Local Government or an OAC shall be <br />produced within twenty-one (21) days of the date the record request was <br />received. This requirement does not supplant any Participating Local <br />Government or OAC's obligations under Washington's Public Records <br />Act RCW 42.56.001 et seq. <br />D. Payment of Counsel and Litigation Expenses <br />1. The Litigating Local Governments have incurred attorneys' fees <br />and litigation expenses relating to their prosecution of claims against the <br />Pharmaceutical Supply Chain Participants, and this prosecution has inured to the <br />benefit of all Participating Local Governments. Accordingly, a Washington <br />8
The URL can be used to link to this page
Your browser does not support the video tag.